Molecular Targeting of Platelet-Derived Growth Factor B by Imatinib Mesylate in a Patient With Metastatic Dermatofibrosarcoma Protuberans
Top Cited Papers
- 1 September 2002
- journal article
- case report
- Published by American Society of Clinical Oncology (ASCO) in Journal of Clinical Oncology
- Vol. 20 (17) , 3586-3591
- https://doi.org/10.1200/jco.2002.01.027
Abstract
PURPOSE: Dermatofibrosarcoma protuberans is caused by activation of the platelet-derived growth factor B (PDGFB) receptor, a transmembrane tyrosine kinase. We investigated the response of dermatofi...Keywords
This publication has 14 references indexed in Scilit:
- Safety and efficacy of imatinib (STI571) in metastatic gastrointestinal stromal tumours: a phase I studyThe Lancet, 2001
- STI571: Targeting BCR-ABL as Therapy for CMLThe Oncologist, 2001
- Effect of the Tyrosine Kinase Inhibitor STI571 in a Patient with a Metastatic Gastrointestinal Stromal TumorNew England Journal of Medicine, 2001
- Dermatofibrosarcoma Protuberans Harboring t(9;22)(q32;q12.2)Cancer Genetics and Cytogenetics, 1999
- Various regions within the alpha-helical domain of theCOL1A1 gene are fused to the second exon of thePDGFB gene in dermatofibrosarcomas and giant-cell fibroblastomasGenes, Chromosomes and Cancer, 1998
- Transforming activity of the chimeric sequence formed by the fusion of collagen gene COL1A1 and the platelet derived growth factor b-chain gene in dermatofibrosarcoma protuberansOncogene, 1998
- Fibrosarcomatous ("High-Grade") Dermatofibrosarcoma ProtuberansThe American Journal of Surgical Pathology, 1998
- Deregulation of the platelet-derived growth factor β-chain gene via fusion with collagen gene COL1A1 in dermatof ibrosarcoma protuberans and giant-cell fibroblastomaNature Genetics, 1997
- Dermatofibrosarcoma protuberans is a unique fibrohistiocytic tumour expressing CD34British Journal of Dermatology, 1992
- Dermatofibrosarcoma ProtuberansAnnals of Surgery, 1967